Therapeutic efficacy of proton pump inhibitor (Omeprazole) on cryptosporidiosis parvum in immunosuppressed experimental mice

doi:10.21203/rs.3.rs-2436725/v1

Download PDF

Research Article

Therapeutic efficacy of proton pump inhibitor (Omeprazole) on cryptosporidiosis parvum in immunosuppressed experimental mice

https://doi.org/10.21203/rs.3.rs-2436725/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 18 May, 2023

Read the published version in Journal of Parasitic Diseases →

You are reading this latest preprint version

Cryptosporidiosis is one of the most frequent food and water-borne diseases. The disease might be life-threatening in immunosuppressed patients. Unfortunately, the only approved drug, nitazoxanide, is with variable efficacies, particularly in malnourished children and immunocompromised patients. Therefore, there is a need to discover an alternative treatment that could be achieved by targeting the metabolic pathways. One of the important enzymes in the glycolysis pathway of C. parvum is triosephosphate isomerase, which could be hindered by the proton pump inhibitor (PPI) omeprazole. In this study, omeprazole was repurposed against C. parvum infection in experimentally immunosuppressed mice. This study was conducted on five mice groups (n = 10). Group I (Normal Control), group II (Infected Control): Mice were infected orally with 1×10⁵ C. parvum oocysts on the 15th day of DEX induced immunosuppression. Group III (NTZ-treated): infected and treated by NTZ. Group IV (Omeprazole-treated), and lastly, Group V (NTZ + Omeprazole-treated). The result obtained with omeprazole alone was better than nitazoxanide regarding oocyst shedding reduction percentages (84.9% & 56.1%, respectively). Also, it was better regarding restoration of histopathological and ultrastructural architectures, improvement of liver enzymes (alanine aminotransferase and aspartate aminotransferase) and renal functions (urea and creatinine), and the reduction of C. parvum triosephosphate isomerase (TIM) gene expression by RT-PCR. However, the best results were obtained with the combined treatment. Hence, omeprazole could be considered a novel drug option to treat this life-threatening parasitic infection either alone or combined with NTZ, especially in immunosuppressed patients.

Cryptosporidium parvum

proton pump inhibitor

TEM

nitazoxanide

omeprazole

triosephosphate isomerase

Cryptosporidium parvum is an apicomplexan protozoan parasite that can infect the microvilli of the gastrointestinal tract in a variety of vertebrates, including humans (Innes et al. 2020). It spreads by fecal-oral route through contaminated food or water with environmentally resistant oocysts (Efstratiou et al. 2017), and rarely by inhalation (Bauerfeind et al. 2016). Cryptosporidium is one of the most frequent causes of waterborne diseases (Pane and Putignani 2022). It comes second after rotavirus as a main worldwide cause of moderate-to-severe pediatric diarrhea (Kotloff et al. 2019). In the same context, it is considered the fourth leading cause of death among children under the age of five (GBD Diarrheal Diseases Collaborators 2017). Also, it was found accountable for 58% of the 936 worldwide reported waterborne outbreaks caused by protozoa between the years 1946 and 2016 (Efstratiou et al. 2017). Cryptosporidium can survive at high chlorine concentrations used in water treatment processes (Adeyemo et al. 2019); therefore, even swimming pools were involved as the source of infection in several outbreaks in Europe (Ma et al. 2022).

After ingestion of the infective oocysts, the released sporozoites invade the enterocytes of the small intestine (Love et al. 2017). The disease has an incubation period of 2–10 days, then it is usually presented either as self-limited gastroenteritis in immunocompetent humans or prolonged chronic illness in immunocompromised patients. Symptoms include watery diarrhea with abdominal pain, nausea, and vomiting; however, non-specific symptoms such as headaches, myalgia, fatigue, and low-grade fever might occur (Blanchard et al. 2015). In severe immunocompromised cases, extraintestinal manifestations involving the biliary tract, pancreas, joints, and respiratory system were also reported (López-Vélez 1995). Unfortunately, the disease may be life-threatening in those patients, as the severity, duration of symptoms, and response to treatment depend on the immune status of the host (Dhal et al. 2022).

The obstacle during the treatment of cryptosporidiosis is that the only approved drug by the (Food and Drug Administration) FDA, nitazoxanide, is with variable efficacies; particularly in malnourished children and immunocompromised patients (Checkley et al. 2015). Also, other available drugs against cryptosporidiosis such as azithromycin, paromomycin, and antiretroviral drugs (Gargala 2008) are not effective with apparent side effects, drug toxicity, and reports of resistance (Abdelmaksoud et al. 2020). Thus, owing to the limited treatment choices for this protozoal infection, there is an urgent need for the discovery of alternative therapies (Rahman et al. 2022).

Fortunately, targeting the metabolic pathways of parasites allows greater opportunities to select new drug treatments (Striepen and Kissinger 2004). In this situation, C. parvum relies mainly on anaerobic glucose oxidation for energy metabolism and the generation of ATP in the glycolytic pathways (Dhal et al. 2022). Nitazoxanide acts against C. parvum by hindering the anaerobic energy transfer reactions through inhibition of the parasitic enzyme pyruvate-ferredoxin oxidoreductase (Fox and Saravolatz 2005). One of the important enzymes in the glycolysis pathway of C. parvum is triosephosphate isomerase, which ensures maximum ATP production (Nguyen et al. 2011).

Proton pump inhibitors (PPIs) belong to a group of benzimidazole-substituted compounds which are safely used to treat gastric and duodenal ulcers, and gastroesophageal reflux disease (García-Torres et al. 2016). Repurposing of the proton pump inhibitor omeprazole against G. lamblia showed cytotoxic effects with simultaneous inactivation of the triosephosphate isomerase enzyme (López-Velázquez et al. 2019). Moreover, PPIs showed antiparasitic effects against Leishmania donovani (Jiang et al. 2002), Trichomonas vaginalis (Shea et al. 2014), Schistosoma mansoni (Dina et al. 2019), and Entamoeba histolytica (Martínez-Pérez et al. 2020). Based on the previous literature, this study aims to evaluate the therapeutic efficacy of the PPI omeprazole compared to nitazoxanide against C. parvum infection in an experimentally immunosuppressed murine model.

Experimental animals

This study was conducted on 50 Swiss albino mice aged 6–8 weeks and weighing on average 20 ± 5 g. Throughout the study, mice were kept under controlled temperature and humidity conditions (25°C; 70%). They were fed on a standard diet and water ad libitum and kept for 15 days adaptation period before inclusion in this trial. All experimental animal studies were conducted under international valid guidelines after approval by the Scientific Research Ethical Committee, Faculty of Medicine Menoufia University (IRB: 1/202/PARA12).

Parasite and infective inoculum

Cryptosporidium parvum oocysts were obtained from the Parasitology department; Theodor Bilharz Research Institute preserved in 2.5% potassium dichromate (K₂Cr₂O₇) solution at 4°C. The infective inoculum was prepared by washing the stored solution with distilled water and repeated centrifugation. Oocysts were concentrated by floatation in Sheather’s sugar solution by centrifugation at 2000 r.p.m. for 10 minutes. The upper third of the solution in each tube was transferred into another tube. Oocysts were washed by centrifugation in distilled water 3 times, then suspended in phosphate-buffered saline (pH 7.2). The infective inoculum was adjusted to contain approximately 1×10⁵ C. parvum oocysts/mouse (Asadpour et al. 2018).

Tested drugs preparation and dosing

Nitazoxanide

Nitazoxanide (NTZ) (Nitazode 100 mg / 5ml, Al Andalous Medical Company, Egypt) was given orally at a dose of 100 mg/kg/d starting on the 10th day p.i. and continued for 7 consecutive days (El-Wakil et al. 2021).

Omeprazole

Omeprazole (Omepral 20 mg capsules, manufactured by Memphis, Pharmaceuticals, Egypt) was dissolved and given orally at a dose of 20 µg/day starting on the 10th day p.i. and continued for 7 consecutive days (Tian et al. 2014).

Induction of immunosuppression

Immunosuppression was induced by giving the synthetic corticosteroid dexamethasone (DEX) (Dexazone 0.5 mg tablets, Kahira Pharmaceuticals and Chemical Industries Company, Cairo, Egypt) orally at a dose of 0.25 µg/kg/day for 14 successive days before inoculation with C. parvum oocysts. The immunosuppressed mice groups continued to receive dexamethasone at the same dose throughout the experiment (Rehg et al. 1988).

Study design

The experimental mice were divided into the following five groups (10 mice each): Group I (Normal Control): a group of healthy mice received saline only. Group II (Infected Control): Mice were infected orally with 1×10⁵ C. parvum oocysts on the 15th day of DEX-induced immunosuppression. Group III (NTZ-treated): Mice were infected and treated by NTZ on the 10th d.p.i at a dose of 100 mg/kg body weight for 7 consecutive days. Group IV (Omeprazole-treated): Mice were infected and treated with omeprazole on the 10th d.p.i at a dose of 20 µg/d for 7 consecutive days. Lastly, Group V (NTZ + Omeprazole-treated): Mice were infected and treated by NTZ combined with omeprazole, as described in GIII and GIV.

Sampling

Fresh fecal pellets from each mouse in the infected groups were collected separately on the 11th, 14th, 17th, 21st, and 24th d.p.i. All the surviving mice were sacrificed by cervical dislocation on the 24th p.i.d. Blood samples were collected, and sera were separated by centrifugation and stored at − 20 ºC for further biochemical studies. From each mouse, the terminal two cm of the ileum and samples from lung tissues were taken and fixed in 10% neutral buffered formalin for histopathological examination. A second part of the ileum was fixed in 5% glutaraldehyde for transmission electron microscopic study (TEM), and a third part of the ileum was immediately stored at – 80 ºC for the molecular study (RT-PCR).

Evaluating the efficacy of treatment

1. Oocyst shedding

Each collected fecal sample was weighted, dissolved in 10% formalin, passed through sterile gauze, and 50 µl was taken and put on glass slides, then stained with the Modified Ziehl-Neelsen stain (cold method). The stained slides were examined under the oil immersion lens (×100) to determine the number of oocysts (Garcia 2007). The oocysts number for each mouse was determined by counting oocysts in ten microscopic fields, and the arithmetic mean was calculated to detect the number of oocysts/grams of feces. The percentage of reduction in oocyst shedding was calculated according to the following equation (Moawad et al. 2021).

$$Reduction \%=\frac{\text{N}\text{u}\text{m}\text{b}\text{e}\text{r} \text{o}\text{f} \text{o}\text{o}\text{c}\text{y}\text{s}\text{t}\text{s} \text{i}\text{n} \text{t}\text{h}\text{e} \text{p}\text{o}\text{s}\text{i}\text{t}\text{i}\text{v}\text{e} \text{c}\text{o}\text{n}\text{t}\text{r}\text{o}\text{l} \text{g}\text{r}\text{o}\text{u}\text{p}- \text{n}\text{u}\text{m}\text{b}\text{e}\text{r} \text{o}\text{f} \text{o}\text{o}\text{c}\text{y}\text{s}\text{t}\text{s} \text{i}\text{n} \text{t}\text{h}\text{e} \text{t}\text{r}\text{e}\text{a}\text{t}\text{e}\text{d} \text{g}\text{r}\text{o}\text{u}\text{p} }{\text{N}\text{u}\text{m}\text{b}\text{e}\text{r} \text{o}\text{f} \text{o}\text{o}\text{c}\text{y}\text{s}\text{t}\text{s} \text{i}\text{n} \text{t}\text{h}\text{e} \text{p}\text{o}\text{s}\text{i}\text{t}\text{i}\text{v}\text{e} \text{c}\text{o}\text{n}\text{t}\text{r}\text{o}\text{l} \text{g}\text{r}\text{o}\text{u}\text{p}}\text{X} 100$$

2. Histopathological study

For each mouse, the preserved ileum and lung tissues in buffered formalin were dehydrated in ascending grades of ethanol, followed by immersion in xylene then impregnated in paraffin blocks, and finally, serial sections of 5 µm in thickness were prepared and stained with hematoxylin and eosin (H & E) (Drury and Wallington 1980).

3. Transmission electron microscopy (TEM)

Intestinal tissue specimens were prepared for Transmission Electron Microscopy (TEM) using the procedures described previously (Winey et al., 2014). Uranyl acetate and lead citrate-stained small intestinal ultrathin sections were examined with a JEOL 1010 Transmission Electron Microscope at the Faculty of Agriculture, El Mansoura University.

4. Real-time PCR for C. parvum triosephosphate isomerase gene expression

Total RNA extraction from ileum tissues was done according to the manufacturer instructions (miRNeasy Mini Kit, QIAGEN, catalog. No. 217004, Applied biosystems, USA). After assurance of RNA content and purity, the first step-PCR or cDNA synthesis (RT-Step) was conducted using the Revert-Aid First Strand cDNA Synthesis Kit (Thermo-Fisher Scientific Inc., USA). The second step-PCR or cDNA amplification with SYBR Green for detection of Cryptosporidium triosephosphate isomerase gene expression was performed utilizing QuantiTect SYBR Green PCR Kit (Applied Biosystems, USA). C. parvum TIM gene primers (Gene ID: 3371710) were forward 5ˋ-GGGTTTGGAGAATGGCCTGA-3ˋ and reverse 5ˋ-GCCCAAATTGGCTCGTAAGC-3ˋ. And GAPDH gene was used as an endogenous control (forward 5ˋ-ACCACAGTCCATGCCATCAC-3ˋ and reverse 5ˋ-TCCACCACCCTGTTGCTGTA-3ˋ). The real-time cycler was programmed according to the following conditions: PCR initial activation step for one minute at 95°C followed by three-step cycling of denaturation for 30 seconds at 95°C, annealing for 30 seconds at 60°C, and final extension for 10 minutes at 72°C. Melting curve analysis was performed to verify the specificity and the identity of the PCR products using 7500 software version 2.0.1.

5. Biochemical studies for alanine aminotransferase, aspartate aminotransferase, urea, and creatinine

Alanine aminotransferase (ALT) and Aspartate aminotransferase (AST) enzyme activities were measured in serum samples according to kits protocols (Sigma-Aldrich, St. Louis, USA). The reactions were read by a fully automated chemistry autoanalyzer (AU 680, Beckman Coulter, California, USA) at 530–550 nm and the activities were expressed as U/L. Moreover, serum urea and creatinine were measured to evaluate renal functions, and the reactions were expressed as mg/dl.

Statistical analysis

Data were collected, tabulated, and statistically analyzed using an IBM-compatible personal computer with Statistical Package for the Social Sciences (SPSS) version 26. Quantitative data were expressed as mean (x̅), standard deviation (SD), and One-way ANOVA (F) test was utilized to compare between over two groups having normally distributed variables followed by Least Significant Difference (LSD) as a post hoc test. Spearman correlation was used to investigate the relationship between oocyst shedding and biochemical changes. Probability of error (P-value) P > 0.05 was not significant, P < 0.05 was significant, and P < 0.001 was highly significant.

1. Oocyst shedding

Regarding oocyst shedding, in the infected control group (GII) the number of oocysts/g of feces × 10³ increased gradually and reached its peak (129.5 ± 3.3) on the 21st p.i.d. then it declined. Oocyst shedding in all treated groups (GIII, GIV & GV) showed statistically significant differences (P ˂ 0.001) when compared to GII.

Omeprazole combined with nitazoxanide showed the best results, followed by omeprazole and lastly nitazoxanide (RP% were 92.3, 84.9, and 56.1, respectively, at the end of the experiment). Omeprazole-treated group (GIV) started on the 14th p.i.d. and continued to the 24th day to show significant differences when compared to the NTZ-treated group (GIII). While the Omeprazole + NTZ-treated group (GV) showed significant differences (P˂0.001) when compared to GIV and GIII throughout the experiment (Table 1).

Table 1

Numbers of oocyst shedding per gram of feces and oocyst reduction percentages on different post infection days
Post infection day	Experimental groups				ANOVA	P value
Post infection day	Infected control (GII) (n = 8)	NTZ-treated (GIII) (n = 10)	OMP-treated (GIV) (n = 10)	OMP + NTZ-treated (GV) (n = 10)	ANOVA	P value
11th day	35.9 ± 2.9 -	24.7 ± 1.9 ^b 31.2%	26.3 ± 2.1 ^b 26.7%	21.4 ± 2.01 ^{b c d} 40.4%	66.579	< 0.001
14th day	49 ± 3.3 -	27.6 ± 1.5 ^b 43.7%	23.1 ± 1.8 ^{b c} 52.9%	16.3 ± 1.9 ^{b c d} 66.7%	369.98	< 0.001
17th day	88.63 ± 4 -	40.8 ± 2.6 ^b 53.9%	22.8 ± 1.8 ^{b c} 74.3%	14.1 ± 1.7 ^{b c d} 84.1%	1407.4	< 0.001
21st day	129.5 ± 3.3 -	59.7 ± 1.9 ^b 53.9%	25.8 ± 1.8 ^{b c} 80.1%	12.8 ± 1.9 ^{b c d} 90.1%	4741.2	< 0.001
24th day	94.4 ± 2.7 -	41.4 ± 2.2 ^b 56.1%	14.2 ± 1.8 ^{b c} 84.9%	7.3 ± 1.5 ^{b c d} 92.3%	3235.8	< 0.001
Number of oocyst shedding/g of feces × 10³ was expressed as M ± SD × 10³. ^a indicates significance when compared to GI, ^b indicates significance when compared to GII, ^c indicates significance when compared to GIII, and ^d indicates significance when compared to GIV.

Histopathological study

Ileal tissue

Histopathological examination of ileum samples obtained from the normal control group (GI) showed preserved crypt-villous ratio with long villi, intact epithelial lining, regular brush border, and normal numbers of goblet cells (Fig. 1a, b). The infected control group (GII) showed disturbed villous architecture with blunted villous tips and broadening of villi, ulceration, and focal sloughing of villous tips in the lumen, focal or total loss of the brush border, and many C. parvum oocysts were found embedded in villous epithelium together with inflammatory cells infiltration in lamina propria and congestion (Fig. 1c, d).

NTZ-treated group (GIII) showed some sort of improvement in surface epithelium with partial restoration of crypt villous ratio and regular brush border. However, focal blunting, thickening of some villi, inflammation and congestion were still present (Fig. 2a). OMP-treated group (GIV) showed obvious restoration of villous architecture, regular brush border with goblet cells, absence of C. parvum oocyst, and minimal inflammation (Fig. 2b, c). While the OMP + NTZ-treated group (GV) showed marked improvement when compared to GIII and GIV. There was a restoration of villous architecture, brush border, goblet cells, minimal inflammation, and absence of the oocysts (Fig. 2d).

Lung tissue

Histopathological sections of lung tissues from the normal control group (GI) showed normal alveoli and bronchi without pulmonary hemorrhage or interstitial inflammation or oocysts at the epithelial lining (Fig. 3a). the infected control group (GII) showed obvious destruction of intra-alveolar septa, pulmonary hemorrhage, focal ulceration, inflammation of the bronchial lamina propria with many cryptosporidium oocysts at the epithelial lining of bronchi (Fig. 3b, c). NTZ-treated group (GIII) showed interstitial inflammation, bronchial inflammation, and pulmonary hemorrhage, but no oocyst at the epithelial lining was detected (Fig. 3d). OMP-treated group (GIV) showed marked improvement with normal epithelial lining of bronchi, mild interstitial inflammation, mild hemorrhage, and no oocysts were found (Fig. 3e). The OMP + NTZ-treated group (GV) showed normal epithelial lining without oocysts, minimal interstitial inflammation, and minimal pulmonary hemorrhage (Fig. 3f).

2. Transmission electron microscopy (TEM)

Transmission electron microscopic study of the ileum tissues obtained from the normal control group (GI) showed normal columnar epithelium, nuclear chromatin, well-developed apical microvilli, mucin-secreting goblet cells, mitochondria of normal shape and number, and intact intracellular junction (Fig. 4a, b). Infected-control group (GII) showed discontinuity, destroyed intracellular junctions, loss of microvilli, shrunken and deformed pyknotic nuclei with a lot of nuclear heterochromatin, fragmented or swollen mitochondria with dilated cristae, and multiple C. parvum oocysts were detected at the site of severely damaged microvilli (Fig. 4c, d, e, f).

NTZ-treated group (GIII) showed partial regeneration of columnar epithelium with prominent microvilli; however, abnormal mitochondria, damaged intracellular junction, pyknotic nuclei, goblet cells with decreased mucin secretion, and cytoplasmic vacuoles were still present (Fig. 5a, b). The OMP-treated group (GIV) showed regenerated columnar epithelium with prominent microvilli, normal nuclei, and intact intracellular junction but occasionally there were fewer mitochondria or fragmentation, dilated Golgi bodies, cytoplasmic vacuoles, and multiple vacuolated C. parvum oocysts were found (Fig. 5c, d, e, f). OMP + NTZ-treated group (GV) showed obvious regeneration of the columnar epithelium with prominent microvilli, normal nuclei, mitochondria of normal shape and number, intact intercellular junctions, and no C. parvum oocyst was seen (Fig. 5g, h).

3. Real-time PCR for C. parvum triosephosphate isomerase gene expression

In the present study, RT-PCR for C. parvum triosephosphate isomerase gene expression fold changes in ileal tissues obtained from all treated groups (GIII, GIV, and GV) were statistically significant (P ˂ 0.001) when compared to the infected control group (GII). There were statistically significant (P ˂ 0.001) differences between OMP-treated (GIV) and OMP + NTZ-treated (GV) when compared to the NTZ-treated group (GIII). However, the difference between GIV and GV was not significant (P = 0.48) (Table 2).

Table 2 Biochemical studies for ALT, AST, urea, creatinine, and C. parvum triosephosphate isomerase gene expression

P value	ANOVA	Experimental Groups					Biochemical and Molecular studies
P value	ANOVA	OMP+NTZ-treated GV (n=10)	OMP- treated GIV (n=10)	NTZ- treated GIII (n=10)	Infected control GII (n=8)	Normal control GI (n=10)	Biochemical and Molecular studies
<0.001	455.99	38.9 ± 2.2 ^{b c}	39.8 ± 2.3 ^{b c}	44.4 ± 1.9 ^{a b}	74.4 ± 1.6^a	39.5 ± 2.01	ALT (U/L)
<0.001	267.04	30 ± 2.4^{b c d}	33.2 ±1.8^{a b c}	37.9 ± 1.5 ^{a b}	58.5 ± 2.5^a	30.8 ± 2.3	AST (U/L)
<0.001	2225.8	27.7 ± 2.21^{b c d}	31.1 ± 2.6 ^b	33 ± 1.8^{a b}	43.1 ± 1.96 ^a	29 ± 2.4	Urea (mg/dl)
<0.001	64.191	1.05 ± 0.05^{a b c d}	1.45 ± 0.05^{a b c}	1.7 ± 0.05 ^{a b}	3.32 ± 0.1^a	0.96 ± 0.01	Creatinine (mg/dl)
<0.001	587.717	0.6 ± 0.02^{b c}	0.64 ± 0.02^{b c}	2.11 ± 0.18^b	2.35 ± 0.16	-	C. parvum triose-phosphate isomerase gene expression (RT-PCR fold changes)

Data were expressed as M ± SD. ^aindicates significance when compared to GI, ^bindicates significance when compared to GII, ^c indicates significance when compared to GIII, and ^dindicates significance when compared to GIV.

4. Biochemical studies for ALT, AST, urea, and creatinine

Liver enzymes

Regarding alanine aspartate aminotransferase results, the infected control group (GII) showed a significant increase (74.4 ± 1.6) when compared to the normal control group (39.5 ± 2.01) (P ˂ 0.001). NTZ-treated group (GIII) showed a significant decrease (44.4 ± 1.9) when compared to the infected control group (GII). However, this decline of ALT value in GIII did not reach the normal value of GI, so the difference between both groups was significant (P ˂ 0.001). Both OMP-treated and OMP + NTZ-treated groups (GIV and GV) showed significant decreases of ALT values reaching normal values. Accordingly, the differences were significant (P ˂ 0.001) when compared to GII, while on comparing both groups to GI and to each other, the differences were statistically not significant (P ˃ 0.05) (Table 2).

Regarding aspartate aminotransferase, the infected control group (GII) showed a significant increase (58.5 ± 2.6) when compared to the normal control group (30.8 ± 2.3) (P ˂ 0.001). NTZ-treated group (GIII) showed a significant decrease (37.9 ± 1.5) when compared to GII. However, this decline of AST value in GIII did not reach the normal value of GI and the difference between both groups was significant (P ˂ 0.001). The OMP-treated group (GIV) showed a significant decrease in the AST value (33.2 ± 1.8) when compared to GII and GIII. As the value was still above normal, the difference was significant (P ˂ 0.001) when compared to GI. While the OMP + NTZ-treated group (GV) showed the return of AST value to the normal, thus the difference between GV and GI was not significant (P = 0.39), but comparing GV to GII, GIII, and GIV were highly significant (P ˂ 0.001) (Table 2).

Renal functions

Regarding serum urea results, the infected control group (GII) showed a significant increase (43.1 ± 1.96) when compared to the normal control group (29.0 ± 2.4) (P ˂ 0.001). NTZ-treated group (GIII) showed a significant decrease (33.0 ± 1.8) when compared to the infected control group (GII). However, this decline of serum urea in GIII did not reach the normal value of GI; thus, the difference between both groups was significant (P ˂ 0.001). Both OMP-treated and OMP + NTZ-treated groups (GIV and GV) showed a significant decrease in serum urea values reaching the normal value. Accordingly, the differences were significant (P ˂ 0.001) when compared to GII, while comparing both groups to GI was not significant (P ˃ 0.05). The best result was obtained in the OMP + NTZ-treated group (GV) which showed highly significant differences when compared to GIII and GIV (Table 2).

Concerning serum creatinine results, the infected control group (GII) showed a highly significant increase (3.32 ± 0.1) when compared to the normal control group (GI) (0.96 ± 0.01) (P ˂ 0.001). NTZ-treated group (GIII) showed a significant decrease (1.7 ± 0.05) when compared to the infected control group (GII). However, serum creatinine in GIII was still significantly higher than in the normal control group (GI) (P ˂ 0.001). Both OMP-treated and OMP + NTZ-treated groups (GIV and GV) showed significant decreases in serum creatinine, but they did not reach the normal value. Accordingly, the differences were significant (P ˂ 0.001) when compared to GII and GIII. The differences were statistically not significant (P ˃ 0.05) when both groups were compared to GI and to each other (Table 2). The results obtained in the OMP + NTZ-treated group (GV) were highly significant when compared to GIV.

Spearman correlation between oocyst shedding and biochemical changes

Spearman correlation test revealed positively significant (P < 0.001) relationships between oocyst shedding numbers and the measured biochemical parameters. The correlation coefficients (r) of ALT, AST, serum urea, and serum creatinine were 0.857, 0.932, 0.843, and 0.951, respectively (Fig. 6).

Results of the current study revealed that oocyst shedding in the infected control group increased gradually and reached its peak on the 21st p.i.d. then it declined. The reduction percentages in all treated groups were statistically significant when compared to the infected control group. Moreover, omeprazole combined with nitazoxanide showed the best therapeutic result (92.3%) followed by omeprazole (84.9%) and lastly nitazoxanide (56.1%).

In the current study, nitazoxanide results agree with Shoultz et al. (2016) who found that nitazoxanide has a cure rate of only 56% in undernourished children. Similarly, Taha et al. (2017) stated a 52.7% reduction percentage of Cryptosporidium oocyst shedding on the 21st day post-infection after nitazoxanide treatment. Also, El-Hawary et al. (2022) reported an oocyst shedding reduction percentage of 54%. The therapeutic efficacy of NTZ in the present study was higher than the results documented by Fahmy et al. (2020) and Esmat et al. (2022) who reported 39% and 38%, respectively.

On the contrary, the results in this study were lower than those obtained by El-Wakil et al. (2021) and Farid et al. (2022) who reported 66% and 92.05%, respectively. This controversy could be attributed to giving NTZ at a different dose and/or duration. For instance, Farid et al. (2022) in their study, gave NTZ at a dose of 100 mg/kg/d continuously for fourteen days; while in this study, NTZ was given at the same dose but for seven days.

In the present study, RT-PCR for C. parvum triosephosphate isomerase gene expression fold change in ileum tissues obtained from all treated groups was statistically significant when compared to the infected control group. Omeprazole alone or combined with NTZ was statistically significant when compared to nitazoxanide alone. The assessment of parasite load by qRT-PCR has an advantage when compared with qPCR as RNA used in the former, due to its quick degradation is considered a better indicator of cell viability than DNA (Zhang and Zhu 2020). Accordingly, the significant reduction of triosephosphate isomerase gene expression which indicates reduced oocyst viability together with reduced oocyst shedding obtained with omeprazole alone or combined with NTZ could be attributed to the successful targeting of this crucial gene in C. parvum glycolysis pathway by omeprazole and the occurrence of a synergistic action between both drugs in the combined-treated group (GV). To the best of our knowledge, this is the first study utilizing omeprazole against cryptosporidiosis in experimental animals. This significant therapeutic efficacy of omeprazole is in accordance with García-Torres et al. (2016)d pez-Velázquez et al. (2019) who stated the effectiveness of omeprazole against G. lamblia and referred this efficacy to the direct inhibition of triosephosphate isomerase enzyme.

Histopathological examination and the ultrastructural study of ileum tissues obtained from the normal control group showed preserved crypt-villous ratio, intact epithelial lining, regular brush border, normal secretory goblet cells, and intact intracellular junctions. While the infected control group showed disturbed villous architecture, ulcerations, inflammatory infiltration in lamina propria, congestion, dysplasia, decreased numbers of goblet cells, focal or total loss of the brush border microvilli, and destroyed intracellular junctions. These pathological alterations induced by C. parvum were in accordance with those observed in several previous studies (Hassan et al. 2021; Moawad et al. 2021; Hassan et al. 2022). Also, it was stated that the columnar epithelial cells and goblet cells decrease in the ileum, reducing the crypt-villous ratio at the time when the number of C. parvum oocysts is the highest (Sasahara et al. 2003). Regarding the ultrastructural findings in both normal and infected control groups, similar observations were reported by Al-Mathal and Alsalem, (2013) and Esmat et al. (2022).

In the current work, treatment with NTZ caused some sort of histopathological improvement with the persistence of C. parvum oocysts, blunting and thickening of some villi, and inflammation. The ultrastructural study also confirmed this partial regeneration of the columnar epithelium. Omeprazole treatment caused an obvious histopathological improvement, restoration of villous architecture, minimal inflammation, normal brush border, and goblet cells. The TEM study revealed regeneration of columnar epithelium with prominent microvilli, normal nuclei, and preserved intracellular junction. The best histopathological and ultrastructural improvements were obtained with the combined OMP + NTZ treatment, which resulted in the complete restoration of villous architecture. These improvements correlate with the oocyst shedding reduction rates obtained with nitazoxanide, omeprazole and omeprazole combined with nitazoxanide (56.1%, 84.9%, and 92.3%, respectively).

In harmony with the current work results, several previous studies reported better therapeutic efficacies of the new drug candidates when they were compared to NTZ in immunosuppressed mice models. For example, El-Wakil et al. (2021) reported a significantly higher therapeutic effect of mefloquine than NTZ on experimental cryptosporidiosis, and 100% oocyst clearance with the restoration of normal epithelial architecture was obtained in the combined group. They explained the partial improvement with NTZ as the impaired immune response decreases the therapeutic efficiency of this drug (Atia et al. 2016; Dhal et al. 2022). Also, Hassan et al. (2022) documented that the treatment with NTZ loaded with silver nanoparticles showed the highest oocyst shedding reduction, with significant improvement in the histopathological changes when compared to NTZ alone. Furthermore, Esmat et al. (2022) stated that NTZ monotherapy showed the least efficacy, and it failed to restore normal intestinal architecture. While the combined clofazimine and NTZ treatment resulted in significant improvements in the parasitological, histopathological, and ultrastructural findings.

In a previous study, Certad et al. (2010) reported respiratory cryptosporidiosis with respiratory failure in immunosuppressed patients. Thus, in the present study, a histopathological examination of lung tissues was done to evaluate the tested drug's therapeutic efficacy. The normal control group showed intact alveoli and bronchi. While, the infected control group showed obvious destruction of intra-alveolar septa, pulmonary hemorrhage, focal ulceration, and inflammation of the bronchial lamina propria with many Cryptosporidium oocysts at the epithelial lining of the bronchi.

Treatment with nitazoxanide resulted in partial improvement, while omeprazole therapy caused an obvious restoration of the normal epithelial linings with mild interstitial inflammation and hemorrhage. Also, the best results were obtained with the combined NTZ + OMP treatment. Madbouly et al. (2017) reported similar results and improvement of lung pathology in the infected immunosuppressed mice after the combined treatment with NTZ and atorvastatin. Also, Moawad et al. (2021) reported similar results in their study on NTZ loaded with chitosan nanoparticles against experimental cryptosporidiosis in immunosuppressed mice.

Regarding ALT and AST results in this study, the infected control group showed a significant increase when compared to the normal control group. NTZ treatment caused significant decreases in ALT and AST when compared to the values of the infected control group. However, this decline did not reach the normal values. On the other side, OMP-treated and OMP + NTZ-treated groups showed significant decreases when compared to infected control and nitazoxanide-treated groups. The combined treatment reverted the elevated liver enzymes to normal values.

In the present study, the significantly increased serum levels of ALT and AST indicates the occurrence of C. parvum-induced hepatocyte damage as serum ALT indicates cell membrane injury while AST denotes mitochondrial damage in hepatic tissues (AbouGabal et al. 2015). These findings are in accordance with Aboelsoued et al. (2019) and Elmahallawy et al. (2020) who recorded elevations of ALT and AST in experimentally infected mice with Cryptosporidium. Which could indicate the extra-intestinal harmful effect of cryptosporidiosis (Chalmers and Davies 2010). In the current study, the Spearman correlation test revealed positively significant relationships between oocyst shedding and serum ALT and AST values. Thus, the restorations of normal values of liver enzymes were correlated to the therapeutic efficacy and oocyst-shedding reduction rates of the tested drugs.

The results of serum urea and creatinine in this study showed highly significant increases in the infected control when compared to the normal control group. The NTZ-treated group showed significant decreases when compared to the infected control group, but they were still significantly higher than the normal values. Both omeprazole and the combined treatment showed significant decreases in serum urea and creatinine values, but creatinine did not reach normal levels. However, the results obtained with the combined treatment were the best. Also, the Spearman correlation test revealed positively significant relationships between oocyst shedding and serum urea and creatinine.

Concerning this obvious renal impairment during this experiment, which correlates with oocyst shedding rates, it is suggested that severe watery diarrhea in immunosuppressed mice might be involved. One of the mechanisms which are thought to contribute to the pathogenesis of Cryptosporidium-induced diarrhea is the impaired intestinal epithelial barrier function and increased permeability (Ott et al. 1991). Disruption of this barrier integrity and function via altering the expression of tight junction (TJs) and adherens junction (AJs) proteins by C. parvum infection were studied. The defects in these barriers have been related to the onset of diarrhea, inflammation, and other extra-intestinal organ affection (Kumar et al., 2018). Interestingly, in the current TEM study, intraepithelial junction destruction was observed in the infected control group with complete restoration after the successful combined treatment.

In the same context, hospitalized diarrheal patients might be complicated with acute kidney injury (AKI) which occurs primarily due to extracellular volume losses from the gastrointestinal tract. These volume losses could be linked to the damaged intestinal TJs which are essential for the maintenance of the electrochemical gradients and transcellular ion transport (Viswanathan et al. 2009). The risk for the development of this renal injury was found higher among HIV/AIDS patients (Bradshaw et al., 2018) which may be attributed to the prolonged course of the disease and the concomitant failure of treatment. Recently, Agnew et al. (2021) reported a case of a postinfectious inflammatory syndrome associated with AKI after C. parvum infection in an immunosuppressed patient. Therefore, renal functions should not be neglected during the follow-up of severe cryptosporidiosis cases, especially in immunocompromised patients.

This study is the first to repurpose the PPI omeprazole against C. parvum infection in experimentally immunosuppressed mice. Omeprazole alone was better than the only FDA-approved drug nitazoxanide regarding oocyst shedding reduction percentage, restoration of histopathological and ultrastructural architectures, improvement of liver enzymes and renal functions, and the reduction of C. parvum triosephosphate isomerase gene expression. However, the best results were obtained with the combined treatment. Thus, further clinical studies are required to evaluate omeprazole as a novel drug option to treat this life-threatening parasitic infection either alone or combined with NTZ, especially in immunosuppressed individuals.

Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Conflict of Interests: The authors declare that they have no conflict of interests.

Author contribution statement

All authors prepared the research protocol and the study design. MM Saleh and FH Shalaan carried out the experimental infection in mice, administrated the therapeutic doses, follow up of the mice, the parasitological study and tissue sampling for biochemical and molecular studies. MA Kora examined the stained ileum and lung sections then interpreted the histopathological results. MM Saleh and EVN Beshay interpreted the transmission electron microscopy results. MM Saleh collected and tabulated the data while EVN Beshay and FH Shalaan participated in analysis and interpretation of the data. EVN Beshay prepared and wrote the manuscript. NE Nassef and O El Shafey critically revised the manuscript. All authors had read and approved the final manuscript version.

Abdelmaksoud HF, El-Ashkar AM, Elgohary SA, El-Wakil ES (2020) Potential therapeutic and prophylactic effects of Asafoetida in murine cryptosporidiosis. J Parasit Dis 44(3): 646-653
Aboelsoued D, Abo-Aziza FAM, Mahmoud MH, Abdel Megeed KN, Abu El Ezz NMT, Abu-Salem FM (2019) Anticryptosporidial effect of pomegranate peels water extract in experimentally infected mice with special reference to some biochemical parameters and antioxidant activity. J Parasit Dis 43(2): 215-228‏
AbouGabal A, Aboul-Ela HM, Ali E, Khaled AEM, Shalaby OK (2015) Hepatoprotective DNA damage prevention and antioxidant potential of spirulina platensis on CCl4-induced hepatotoxicity in mice. Am J Biomed Res (3): 29–34
Adeyemo FE, Singh G, Reddy P, Bux F, Stenstrom TA (2019) Efficiency of chlorine and UV in the inactivation of Cryptosporidium and Giardia in wastewater. PLoS One.14(5):e0216040. https://doi.org/10.1371/journal.pone.0216040
Agnew M, Kottapalli A, Kottapalli V. (2021) Postinfectious Inflammatory Syndrome following Cryptosporidium Infection. Case Reports in Gastroenterology 15:772-778
Al-Mathal EM, Alsalem AA (2013) Pomegranate (Punica granatum) peel is effective in a murine model of experimental Cryptosporidium parvum ultrastructural studies of the ileum. Exp Parasitol 134(4): 482-494‏
Asadpour M, Namazi F, Razavi SM, Nazifi S (2018) Curcumin: a promising treatment for Cryptosporidium parvum infection in immunosuppressed BALB/c mice. Exp Parasitol 195: 59-65
Atia MM, Abdul Fattah MM, Abdel Rahman HA, Mohammed FA, Al-Ghandour AMF (2016) Assessing the efficacy of nitazoxanide in treatment of Cryptosporidiosis using PCR examination. J Egypt Soc Parasitol 46(3):683–692
Bauerfeind R, Von Graevenitz A, Kimmig P, Schiefer HG, Schwarz TF, Slenczka W, Zahner H (2016) Zoonoses: infectious diseases transmissible between animals and humans, 4th edn. ASM Press, Washington, DC
Blanchard SS, Gold BD, Czinn S. (2015) Pediatrics & Therapeutics Giardiasis and Cryptosporidiosis - Recent Literature with a Focus on Nitazoxanide 2015 5:4 http://dx.doi.org/10.4172/2161-0665.1000265
Bradshaw C, Zheng Y, Silver SA, Chertow GM, Long J, Anand S. (2018) Acute kidney injury due to diarrheal illness requiring hospitalization: data from the National Inpatient Sample. J General Inter Med 33(9): 1520-1527
Certad G, Creusy C, Guyot K, Mouray A, Chassat T, Delaire B, Pinon A, Sitja-Bobadilla A, Alvarez-Pellitero P, Praet M, Cuvelier C, Dei-Cas E (2010) Fulminant cryptosporidiosis associated with digestive adenocarcinoma in SCID miceinfected with Cryptosporidium parvum TUM1 strain. Int J Parasitol 40:1469–1475
Chalmers RM, Davies AP (2010) Minireview: Clinical cryptosporidiosis. Exp Parasitol 124: 138–146
Checkley W, White AC Jr, Jaganath D, Arrowood MJ, Chalmers RM, Chen XM, Fayer R, Griffiths JK, Guerrant RL, Hedstrom L, Huston CD et al (2015) A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for Cryptosporidium. Lancet Infect Dis 15(1):85-94
Dhal AK, Panda C, Yun SI, Mahapatra RK (2022) An update on Cryptosporidium biology and therapeutic avenues. J Parasit Dis 1-17
Dina I, Asmaa R, Amira E, Hanan AA (2019) Omeprazole as an Adjuvant to Praziquantel in Treatment of Experimental Schistosomiasis Mansoni. The Medical Journal of Cairo University 87: 3127-3135‏
Drury RA, Wallington EA (1980) Carleton histological techniques, 5th edn. Oxford University Press, Oxford
Efstratiou A, Ongerth JE, Karanis P (2017) Waterborne transmission of protozoan parasites: review of worldwide outbreaks—an update 2011–2016. Water Res 114:14–22. https://doi.org/10.1016/j.watres.2017.01.036
El-Hawary SS, Kirollos FN, Taha KF, Dahab AA, El-Mahis AA, El-Sayed SH (2022) Potential effect of methanol leaf extracts from three Podocarpus species on experimental cryptosporidiosis. Trop Biomed 39(1): 99-107.
Elmahallawy EK, Elshopakey GE, Saleh AA, Agil A, El-Morsey A, El-Shewehy D M, Abdo W (2020) S-Methylcysteine (SMC) ameliorates intestinal, hepatic, and splenic damage induced by Cryptosporidium parvum infection via targeting inflammatory modulators and oxidative stress in swiss albino mice. Biomed 8(10): 423
El-Wakil ES, Salem AE, Al-Ghandour AMF (2021) Evaluation of possible prophylactic and therapeutic effect of mefloquine on experimental cryptosporidiosis in immunocompromised mice. J Parasit Dis 45:380–393. https:// doi. org/ 10. 1007/ s12639- 020- 01315-4
Esmat M, Abdel-Aal AA, Shalaby MA, Badawi M, Elaskary H, Yousif AB, Fahmy MA (2022) Efficacy of clofazimine and nitazoxanide combination in treating intestinal cryptosporidiosis and enhancing intestinal cellular regeneration in immunocompromised mice. Food Waterborne Parasitol. 4:27:e00161.
Fahmy MEA, Abdelaal AA, Hassan SI, Shalaby MA, Ismail MA, Khairy RA, Fadl HO (2020) Potential immunomodulatory effect of single and combined therapies against Cryptosporidium infection in immunosuppressed mouse model. J Egypt Soc Parasitol 50(3): 673-682
Farid A, Yousry M, Safwat G (2022) Garlic (Allium sativum Linnaeus) improved inflammation and reduced cryptosporidiosis burden in immunocompromised mice. J Ethnopharmacol 292: 115174‏
Fox LM, Saravolatz LD (2005) Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis 40(8):1173–1180. https://doi.org/10.1086/428839
Garcia LS (2007) Clinically important human parasites, intestinal protozoa, Cryptosporidium spp. In: Diagnostic medical parasitology. L.S. Garcia, 5th edn, vol 2, pp 771–812. ASM press, Washington DC
García-Torres I, de la Mora-de la Mora I, Marcial-Quino J, Gómez-Manzo S, Vanoye-Carlo A, Navarrete-Vázquez G, Colín-Lozano B, Gutiérrez-Castrellón P et al (2016) Proton pump inhibitors drastically modify triosephosphate isomerase from Giardia lamblia at functional and structural levels, providing molecular leads in the design of new antigiardiasic drugs. Biochimica et Biophysica Acta (BBA)-General Subjects 1860(1):97-107
Gargala G (2008) Drug treatment and novel drug target against Cryptosporidium. Parasite 15:275–281
GBD Diarrhoeal Diseases Collaborators (2017). Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis 17: 909–948. https://doi.org/10.1016/S1473-3099(17)30276-1
Hassan ZR, Hussein FO, Rabia IS, Abd Rabbo MA (2021) Effect of silver nanoparticles loaded nitazoxanide in the treatment of murine cryptosporidiosis in immunocompetent and immunosuppressed mice. Al-Azhar Univ J Virus Res Stud 3(1):1–15. https://doi.org/10.1007/s12639-020-01337-y
Hassan ZR, Salama DE, Ibrahim HF (2022) Apoptotic changes in the intestinal epithelium of Cryptosporidium-infected mice after silver nanoparticles treatment versus nitazoxanide. J Parasit Dis 46(4): 1011-1020
Innes EA, Chalmers RM, Wells B and Pawlowic MC (2020) A one health approach to tackle cryptosporidiosis. Trends Parasitol 36: 290–303
Jiang S, Meadows J, Anderson SA, and Mukkada AJ (2002). Antileishmanial activity of the antiulcer agent omeprazole. Antimicrob Agents Chemother 46(8): 2569-2574
Kotloff KL, Nasrin D, Blackwelder WC, Wu Y, Farag T, Panchalingham S, Sow SO, Sur D, Zaidi AKM, Faruque ASG, Saha D, Alonso PL, Tamboura B et al (2019) The incidence, etiology, and adverse clinical consequences of less severe diarrheal episodes among infants and children residing in low-income and middle-income countries: a 12-month case-control study as a follow-on to the Global Enteric Multicenter St. Lancet Glob Health 7(5): e568–e584. https://doi.org/10.1016/S2214-109X(19)30076-2
Kumar A, Chatterjee I, Anbazhagan AN, Jayawardena D, Priyamvada S, Alrefai WA, Dudeja PK (2018) Cryptosporidium parvum disrupts intestinal epithelial barrier function via altering expression of key tight junction and adherens junction proteins. Cell Microbiol 20(6): e12830
López-Velázquez G, Fernández-Lainez C, Caudillo de la Portilla D, Reynoso-Robles R, González-Maciel A, Ridaura C, Enríquez-Flores S (2019) On the molecular and cellular effects of omeprazole to further support its effectiveness as an antigiardial drug. Scientific Reports 9(1): 1-14
López-Vélez R, Tarazona R, Garcia Camacho A, Gomez-Mampaso E, Guerrero A, Moreira V, Villanueva R (1995) Intestinal and extraintestinal cryptosporidiosis in AIDS patients. Eur J Clin Microbiol Infect Dis 14: 677-681
Love MS, Beasley FC, Jumani RS, Wright TM, Chatterjee AK, Huston CD, McNamara CW (2017) A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis. PLoS Negl Trop Dis 11(2): e0005373‏
Ma JY, Li MY, Qi ZZ, Fu M, Sun TF, Elsheikha HM, Cong W. (2020) Waterborne protozoan outbreaks: An update on the global, regional, and national prevalence from 2017 to 2020 and sources of contamination. Sci Total Environ 806(Pt2):150562. https://doi.org/10.1016/j.scitotenv.2021.150562
Madbouly NT, Hebat SA, Yousof HA, El-Sayed SH, Younis AI, Mohamed SJ (2017) Atorvastatin repurposing for the treatment of cryptosporidiosis in experimentally immunosuppressed mice. Exp Parasitol 181:57–69
Martínez-Pérez Y, Nequiz-Avendaño M, García-Torres I, Gudiño-Zayas ME, López-Velázquez G, Enríquez-Flores S, Mendoza E, Saavedra E, Pérez-Tamayo R, León-Avila G, Olivos-García A (2020) Rabeprazole inhibits several functions of Entamoeba histolytica related with its virulence. Parasitol Res 119(10): 3491-3502
Moawad HSF, Hegab MHAE, Badawey MSR, Ashoush SE, Ibrahim SM, Ali AAES (2021) Assessment of chitosan nanoparticles in improving the efficacy of nitazoxanide on cryptosporidiosis in immunosuppressed and immunocompetent murine models. J Parasit Dis 45(3):606–619
Nguyen TN, Abendroth J, Leibly DJ, Le KP, Guo W, Kelley A, Van Voorhis WC (2011) Structure of triosephosphate isomerase from Cryptosporidium parvum. Acta Crystallographica Section F: Structural Biology and Crystallization Communications 67(9): 1095-1099
Ott M, Lembcke B, Staszewski S, Helm EB, Caspary WF (1991) Intestinal permeability in patients with acquired immunodeficiency syndrome (AIDS). Klinische Wochenschrift, 69(15): 715-721.‏
Pane S, Putignani L (2022) Cryptosporidium: Still Open Scenarios. Pathogens 11(5):515. https://doi.org/10.3390/pathogens11050515
Rahman SU, Mi R, Zhou S, Gong H, Ullah M, Huang Y, Han X and Chen Z (2022) Advances in therapeutic and vaccine targets for Cryptosporidium: challenges and possible mitigation strategies, Acta Trop. 226: 106273
Rehg JE, Hancock ML, Woodmansee DB (1988) Characterization of a dexamethasone treated rat model of cryptosporidial infection. J Infect Dis 158:1406–1407
Sasahara T, Maruyama H, Aoki M, Kikuno R, Sekiguchi T, Takahashi A, Satoh Y, Kitasato H, Takayama Y, Inoue M (2003) Apoptosis of intestinal crypt epithelium after Cryptosporidium parvum infection. J Infect Chemother 9(3):278–281.
Shea TA, Burburan PJ, Matubia VN, Ramcharan SS, Rosario I Jr, Parkin DW, Stockman BJ (2014) Identification of proton-pump inhibitor drugs that inhibit Trichomonas vaginalis uridine nucleoside ribohydrolase. Bioorganic & Medicinal Chemistry Letters 24(4): 1080-1084
Shoultz DA, De-Hostos EL, Choy RKM (2016) Addressing Cryptosporidium Infection among Young Children in Low- Income Settings: The Crucial Role of New and Existing Drugs for Reducing Morbidity and Mortality. PLoS Neglect Trop Dis 10: e0004242. https://doi.org/10.1371%2Fjournal.pntd.0004242
Striepen B, Kissinger JC (2004) Genomics meets transgenics in search of the elusive Cryptosporidium drug target. Trends Parasitol 20(8):355–358. https://doi.org/10.1016/j.pt.2004.06.003
Taha NM, Yousof HS, EL-Sayed SH (2017) Atorvastatin repurposing for the treatment of cryptosporidiosis in experimentally immunosuppressed mice. Exp Parasitol 181: 57-69. https://doi.org/10.1016/j.exppara. 2017.07.010
Tian A, Xu T, Liu K, Zou Q, Yan X (2014) Anti-Helicobacter pylori effect of total alkaloids of Sophora alopecuroides in vivo. Chin Med J 127(13): 2484-2491.‏
Viswanathan VK, Hodges K, Hecht G (2009) Enteric infection meets intestinal function: How bacterial pathogens cause diarrhea. Nature Reviews. Microbiol 7(2): 110–119. https://doi.org/10.1038/nrmicro2053
Zhang H, Zhu G (2020) High-throughput screening of drugs against the growth of Cryptosporidium parvum in vitro by qRT-PCR. In: Cryptosporidium. Springer, pp 319–334. https://doi.org/10.1007/978-1-4939-9748-0_18
Winey M, Meehl JB, O'Toole ET, Giddings Jr TH (2014) Conventional transmission electron microscopy. Molecular Biol of the cell 25(3): 319-323

Download PDF

Journal Publication

published 18 May, 2023

Read the published version in Journal of Parasitic Diseases →

Reviewers agreed at journal
14 Jan, 2023
Reviewers invited by journal
05 Jan, 2023
Editor assigned by journal
03 Jan, 2023
First submitted to journal
02 Jan, 2023

You are reading this latest preprint version

Therapeutic efficacy of proton pump inhibitor (Omeprazole) on cryptosporidiosis parvum in immunosuppressed experimental mice

Status:

Journal Publication

Version 1

Abstract

Figures

Introduction

Materials And Methods

Experimental animals

Parasite and infective inoculum

Tested drugs preparation and dosing

Nitazoxanide

Omeprazole

Induction of immunosuppression

Study design

Sampling

Evaluating the efficacy of treatment

1. Oocyst shedding

2. Histopathological study

3. Transmission electron microscopy (TEM)

4. Real-time PCR for C. parvum triosephosphate isomerase gene expression

5. Biochemical studies for alanine aminotransferase, aspartate aminotransferase, urea, and creatinine

Statistical analysis

Results

1. Oocyst shedding

Histopathological study

Ileal tissue

Lung tissue

2. Transmission electron microscopy (TEM)

4. Biochemical studies for ALT, AST, urea, and creatinine

Liver enzymes

Renal functions

Spearman correlation between oocyst shedding and biochemical changes

Discussion

Conclusion

Declarations

References

Status:

Journal Publication

Version 1